This was further confirmed by increased levels of circulating type I (IFNα), type II (IFNγ) and type III IFN seen in the SARS+ compared to SARS- group (Figure 2), with a significantly higher IFNγ in those with moderate/severe COVID-19 compared to mild COVID-19. The gene discussed is IFNA2; the disease is COVID-19.